Sfoglia per Autore
Mechanism of uremic osteodystrophy and prevention of hyperparathyroidism in the uremic patient
2003 D. Brancaccio, M. Cozzolino, A. Galassi, A. Bellasi, P. Carpani, M. Gallieni
Prevenzione delle calcificazioni extrascheletriche nel paziente uremico
2005 M. Cozzolino, A. Galassi, A. Bellasi, A. Butti, U. Zoni, M. Gallieni, D. Brancaccio
Pathogenesis of parathyroid hyperplasia in renal failure
2005 M. Cozzolino, D. Brancaccio, M. Gallieni, A. Galassi, E. Slatopolsky, A. Dusso
Abnormal variations in the facial soft tissues of adult uremic patients on chronic dialysis
2005 V.F. Ferrario, C. Sforza, C. Dellavia, A. Galassi, D. Brancaccio
Nuove acquisizioni nella patogenesi dell'iperparatiroidismo secondario = New insights in the pathogenesis of secondary hyperparathyroidism
2005 M. Cozzolino, A. Butti, G. Chiarelli, L. Rocca-Rey, A. Bellasi, A. Galassi, M. Gallieni, D. Brancaccio
Facial changes in adult uremic patients on chronic dialysis: possible role of hyperparathyroidism
2005 V. F. Ferrario, C. Sforza, C. Dellavia, A. Galassi, L. Rocca Rey, G. Chiarelli, M. Cozzolino, M. Gallieni, D. Brancaccio
Matrix GLA protein gene polymorphisms : clinical correlates and cardiovascular mortality in chronic kidney disease patients
2005 D. Brancaccio, M.L. Biondi, M. Gallieni, O. Turri, A. Galassi, F. Cecchini, D. Russo, V. Andreucci, M. Cozzolino
Serum fetuin-A levels link inflammation and cardiovascular calcification in hemodialysis patients
2006 M. Cozzolino, A. Galassi, M.L. Biondi, O. Turri, S. Papagni, N. Mongelli, L. Civita, M. Gallieni, D. Brancaccio
Decreased serum fetuin-A levels after a single haemodialysis session
2007 M. Cozzolino, A. Galassi, M.L. Biondi, A. Butti, M. Russo, C. Longhini, M. Gallieni, D. Brancaccio
Cinacalcet, paricalcitol, or both?
2007 M. Cozzolino, A. Galassi, D. Brancaccio
Preventive measures and new pharmacological approaches of calcium and phosphate disorders
2008 M. Cozzolino, A. Galassi, S. Pasho, G. Fallabrino, M. Gallieni, D. Brancaccio
Impaired brachial artery endothelial flow-mediated dilation and orthostatic stress in hemodialysis patients
2008 M.A. Gallieni, A. Butti, M. Guazzi, A. Galassi, M.G. Cozzolino, D. Brancaccio
Pathogenesis and treatment of secondary hyperparathyroidism in dialysis patients : the role of paricalcitol
2008 M.G. Cozzolino, A. Galassi, M.A. Gallieni, D. Brancaccio
Awareness of hypertension and proteinuria in randomly selected patients in 11 Italian cities. A 2005 report of the National Kidney Foundation of Italy
2009 A. Galassi, D. Brancaccio, M. Cozzolino, G. Bellinghieri, U. Buoncristiani, F. Cavatorta, L. D'Apice, B. Di Iorio, L. Gesualdo, S. Gianni, B. Ricciardi, D. Russo, V. Andreucci
Arterial accelerated aging in dialysis patients: the clinical impact of vascular calcification
2009 D. Brancaccio, A. Bellasi, M. Cozzolino, A. Galassi, M. Gallieni
Vascular calcification and cardiovascular outcome in dialysis patients : the role of gene polymorphisms
2010 M. Cozzolino, M.L. Biondi, A. Galassi, D. Cusi, D. Brancaccio, M. Gallieni
What would we like to know, and what do we not know about fibroblast growth factor 23?
2011 M. Cozzolino, A. Galassi, M. Apetrii, A. Covic
Clinical significance of FGF-23 measurement in dialysis patients
2011 F. Jongbloed, A. Galassi, M. Cozzolino, R. Zietse, G. Chiarelli, D. Cusi, D. Brancaccio, M. Gallieni
Phosphate handling in CKD-MBD from stage 3 to dialysis and the three strengths of lanthanum carbonate
2012 M. Cozzolino, E. Bruschetta, D. Cusi, E. Montanari, M.E. Giovenzana, A. Galassi
Paricalcitol and Cardiorenal Outcome : From the IMPACT Study to Clinical Practice
2013 A. Bellasi, A. Galassi, P. Salvi, M. Cozzolino
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile